Lincoln, MA, United States of America

Francis P Tally

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Cubist Pharmaceuticals, Incorporated. Active years: 2002-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis P Tally. Retrieved from https://idiyas.com/inventor/francis-p-tally

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 119(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Francis P. Tally

Introduction

Francis P. Tally is a notable inventor based in Lincoln, MA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 5 patents, Tally has focused on developing methods that enhance the efficacy of antibiotic administration while minimizing adverse effects.

Latest Patents

One of Tally's latest patents is titled "Methods for administration of antibiotics." This invention provides methods for administering a therapeutically effective amount of daptomycin while minimizing skeletal muscle toxicity. The methods allow for daptomycin administration at a dosing interval of 24 hours or greater, which minimizes muscle toxicity and permits higher peak concentrations of the drug, thereby enhancing its efficacy. Additionally, the invention outlines methods for administering other lipopeptide antibiotics and quinupristin/dalfopristin, ensuring that muscle toxicity is minimized through appropriate dosing intervals.

Another significant patent is "Method for identifying validated target and assay combination for drug development." This invention comprises methods useful for identifying compounds that produce a desired phenotype, such as growth inhibition, in specific cells. The process involves constructed cells with a regulable gene encoding a biomolecule that modulates the function of a target component, such as an enzyme. The invention also includes methods for identifying biomolecules that bind to the target cell component and modulate its function, leading to a phenotypic effect.

Career Highlights

Francis P. Tally is currently associated with Cubist Pharmaceuticals, Incorporated, where he continues to innovate in the pharmaceutical sector. His work has significantly impacted the development of antibiotics and drug discovery processes.

Collaborations

Tally has collaborated with notable colleagues, including Jianshi Tao and Philip A. Wendler, contributing to advancements in pharmaceutical research and development.

Conclusion

Francis P. Tally's innovative work in antibiotic administration and drug development exemplifies the importance of research in enhancing therapeutic efficacy while minimizing side effects. His contributions continue to shape the future of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…